The key to infection control in the intensive care unit (ICU) is to appreciate that a limited range of potentially pathogenic micro-organisms, both 'normal', including Streptococcus pneumoniae, Haemophilus and Staphylococcus aureus, and 'abnormal', such as aerobic Gram-negative bacilli, may cause three different types of infection, each requiring a different prophylactic manoeuvre 1 . Exogenous infections may be controlled by a high level of hygiene, primary endogenous infections by the immediate administration of parenteral antibiotics and secondary endogenous infections by the application of enteral antimicrobials in throat and gut 2 .
Selective decontamination of the digestive tract (SDD) using hygiene and parenteral and enteral antimicrobials is a prophylactic measure aiming at the control of exogenous, primary endogenous and secondary endogenous infections, and at the reduction in mortality 1, 2 . Twelve systematic reviews and meta-analyses of randomised controlled trials Impact of selective decontamination of the digestive tract on carriage and infection due to Gram-negative and Gram-positive bacteria: a systematic review of randomised controlled trials L. SILVESTRI*, H. K. F. VAN SAENE †, A. CASARIN ‡, G. BERLOT §, A. GULLO** SUMMARY Meta-analyses of randomised controlled trials of selective digestive decontamination have clinical outcome measures, mainly pneumonia and mortality. This meta-analysis has a microbiological endpoint and explores the impact of selective digestive decontamination on Gram-negative and Gram-positive carriage and severe infections. We searched electronic databases, Cochrane Register of Controlled Trials, previous meta-analyses and conference proceedings with no language restrictions. We included randomised controlled trials which compared the selective digestive decontamination protocol with no treatment or placebo. Three reviewers independently applied selection criteria, performed the quality assessment and extracted the data. The outcome measures were carriage and severe infection due to Gram-negative and Gram-positive bacteria. Odds ratios were pooled with the random effect model. Fifty-four randomised controlled trials comprising 9473 patients were included; 4672 patients received selective digestive decontamination and 4801 were controls. Selective digestive decontamination significantly reduced oropharyngeal carriage (odds ratio [OR] 0.13, 95% confidence interval [CI] 0.07 to 0.23), rectal carriage (OR 0.15, 95% CI 0.07 to 0.31), overall infection (OR 0.17, 95% CI 0.10 to 0.28), lower respiratory tract infection (OR 0.11, 95% CI 0.06 to 0.20) and bloodstream infection (OR 0.35, 95% CI 0.21 to 0.67) due to Gram-negative bacteria. Reduction in Gram-positive carriage was not significant. Gram-positive lower airway infections were significantly reduced (OR 0.52, 95% CI 0.34 to 0.78). Gram-positive bloodstream infections were not significantly increased (OR 1.03, 95% CI 0.75 to 1.41) . The association of parenteral and enteral antimicrobials was superior to enteral antimicrobials in reducing carriage and severe infections due to Gram-negative bacteria. This meta-analysis confirms that selective digestive decontamination mainly targets Gram-negative bacteria; it does not show a significant increase in Gram-positive infection. manoeuvre of SDD [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . The majority of them focused  on a clinical endpoint, mainly pneumonia 3-10,12 , bloodstream infection 7,10,14 and mortality [3] [4] [5] [6] [7] [8] [9] 11, 12, 14 . SDD bloodstream infection and mortality to 0.35 (95% CI 0.29 to 0.41) 12 , 0.63 (0.46 to 0.87) 14 and 0.78 (0.68 to 0.89) 12 respectively. However, none of those meta-analyses assessed the impact on the microbiology of the digestive tract carriage and only two distinguished the type of micro-organism causing infections, one included a small sample of liver transplant patients 11 and the other evaluated only patients with bloodstream infection 14 . Additionally, refute the fear that the widespread use of SDD will lead to a serious Gram-positive problem.
We performed a systematic review and metaanalysis of randomised controlled trials of SDD to explore the impact of SDD on carriage and severe infections due to Gram-negative and Gram-positive bacteria.
MATERIALS AND METHODS

Identification of relevant literature and retrieval of studies
We searched Medline (January 1976 to June 2006), Embase (January 1980 to June 2006) and the Cochrane Register of Controlled Trials (June 2006). We use the search terms "intensive care unit", "critical care", "antibiotic combined therapeutic use", "antibiotic combined administration and dosages", "decontamination", "respiratory tract infection prevention and control", "bacterial infection", with the keywords "SDD", "selective decontamination", "selective digestive decontamination", "digestive decontamination", "bowel decontamination". No language restriction was applied. Additionally, we checked reference lists of previous systematic papers of SDD, searched conference abstracts subject.
Inclusion and exclusion criteria
Inclusion and exclusion criteria were established by the investigators before reviewing abstracts and articles. We included all randomised trials comparing enteral administration of antibiotics of SDD (oropharyngeal, intestinal or both), with or without a parenteral component, with no treatment or placebo in the controls. All published and unpublished trials in unselected and selected critically ill patients were considered. RCTs with in the meta-analysis. Studies were excluded for the following reasons: 1) studies including neutropaenic, stem cell and bone marrow transplant patients; 2) non-randomised studies; 3) double publications; 4) studies including data extracted from or complementing main publications; 5) both study arms received SDD but evaluated another drug; and 6) endpoint not infection.
Data extraction and quality assessment
Three investigators (LS, HKFvS, AC)
from each study and compared the sets of data. Any disagreement was resolved by reinspection of the original data and discussion. Where data were available all randomised patients were included in the analysis, allowing an intention-to-treat analysis.
The following data were sought for each study: type and routes; number of patients in each arm; total number of carriers; number of patients with oropharyngeal and rectal carriage due to Gram-negative bacteria; number of patients with Gram-negative infection; number of patients with Gram-negative infection of the lower airways and the bloodstream. Identical variables were sought for Gram-positive bacteria.
We assessed the quality of each study according a scoring system ranging from 0 to 14 and derived by Heyland et al 6 15 , and previously described 14 . The assessment was made by three investigators (LS, HKFvS, AC) and included randomisation, blinding, patient selection, population description, reproducibility and was obtained as the sum of the subscores of the three evaluators for each of the seven dimensions.
Statistical analysis
The primary endpoints were overall carrier state, patients with oropharyngeal and rectal carriage due to Gram-negative and Gram-positive bacteria, patients with overall Gram-negative and Grampositive infections, and patients with infections of the lower airway and the bloodstream due to Gramnegative and Gram-positive bacteria.
A subgroup analysis of primary endpoints was planned a priori. To analyse the effect of SDD on the studied variables, RCTs were grouped according to: 1) type of regimen used (parenteral plus enteral or enteral only); 2) quality of randomisation procedures (adequate or inadequate); 3) blinding of patients and caregivers to allocated treatment (blinded or not-blinded); and 4) quality of the study (high or low) 16 . Randomisation was adequate when patients A study was blinded when caregivers and outcome assessors were blinded. The quality categories were obtained according to the median value of the quality scores of all studies. Moreover, an additional subgroup analysis of only infectious endpoints due a priori in order to analyse the impact of SDD in studies where successful decontamination was achieved. A for oropharyngeal or rectal or overall carriage due to Gram-negative micro-organisms was less than the unit in each study.
Results were presented as odds ratios (OR) with effects model. The random effects model provides a more conservative estimate of the 95% CI, taking heterogeneity into account: 0.5 cases were added to empty cells to allow calculation of ORs. The ORs were less than the unit if the outcome occurred less frequently in the SDD group. The Cochrane Q statistic for heterogeneity was used both for the outcome measures and through subgroup analyses;
P value was <0.10. We also evaluated the I 2 measure of inconsistency with the formula 100%×(Q-df)/ Q, where Q is Cochrane's Q statistics and df is the degree of freedom (number of studies-1). Negative values of I 2 were put equal to 0%, which indicated no observed heterogeneity, while larger percentages indicated increasing heterogeneity. We 2 measure greater than 50% 17 . We examined a funnel diagram of the log of the ORs against the weight to estimate potential publication bias. Computations were performed using the EasyMA software 18 .
RESULTS
Search findings and general description of the studies
We evaluated 124 potentially eligible studies ( Figure 1 ). Of these studies, 68 were excluded: 47 studies were not randomised, 18 were double publications or included data extracted from the main publication and in three studies both arms received SDD and evaluated another drug. We addition, two studies were excluded because infection or carriage were not the endpoints 19, 20 .
9473 patients (4672 SDD e 4801 control), was the basis for the systematic review and meta-analysis .
The details of each study are described in Table 1 . One trial was split into two parts in which two different treatments were compared with the same control group 70 . Data from the Lingnau's study were retrieved from an additional paper on the microbiology of the same study 75 . In one study, one of the two control arms receiving only sucralfate was excluded 51 . Of the 54 trials, two were published as abstract 28, 37 . Four trials were performed in paediatric intensive care units 24, 61, 64, 73 selected types of patients included liver transplantation 23, 26, 44, 56, 64, 74 , burns 24, 34 , cardiac 29, 38, 73 and gastric surgery 63 , oesophageal resection 67 , pancreatitis 51 , neurosurgery 45, 47, 69 , stroke 42 and acute liver failure 59, 60 . The decontamination protocol varied among 23, 24, 28, 29, 31, 32, 34, 39, 42, 43, 47, 48, 50, 54, 55, 57, 58, 62, 63, 65, 70 and in 16 studies the randomisation was adequate 25, 29, [31] [32] [33] [34] 42, 47, 48, 55, 57, [62] [63] [64] 73, 74 . The methodological quality assessment for all trials showed a median of 9.3 (interquartile range 8 to 11) and a weighted kappa on agreement of 0.50 (95% CI, 0.24 to 0.75).
Overall bacterial carriage
Nine studies including 1178 patients (562 SDD, 616 control) reported information on the carrier state, without citing the type of microorganisms 21, 22, 24, 25, 33, 49, 50, 55, 58 of the SDD group and in 381 patients of the control group (61.8%) developed a carrier state. SDD 0.11, 95% CI 0.05 to 0.26, P <0.001). The test for 2 8.97, P=0.34; I 2 10.81%).
Carriage and infection due to Gram-negative bacteria
Results from 20 RCTs including 3547 patients (1789 SDD, 1758 control) were available for the analysis of Gram-negative oropharyngeal carriage 21, 26, 35, 36, 38, 42, 43, [45] [46] [47] 50, 52, 57, 61, 63, 65, 68, 69, 71, 73 . There were 141 (7.9%) carriers in the SDD group and 536 (30.5%) in the controls. The results indicated a protective effect of SDD on Gram-negative carrier state of the oropharynx (OR 0.13; 95% CI 0.07 to 0.23, P <0.001) ( Figure 2 ). The test for heterogeneity ( 2 17.69, P=0.54; I 2 0%).
Data on rectal carriage were retrieved from 15 RCTs including a total of 1942 patients (971 SDD, 971 control) 23, 26, 29, 30, 43, 46, 47, 50, 56, 57, 65, 67, 68, 71, 73 . There were 69 (7.1%) carriers in the SDD group and 346 (35.6%) Gram-negative rectal carrier state (OR 0.15, 95% CI 0.07 to 0.31, P <0.001). The test for 2 15.41, P=0.38,
Eight studies comprising of 923 patients (451 SDD, 472 control) included data on overall Gramnegative infections with any report of the infection site 21, 23, 30, 33, 44, 55, 62, 64 . There were 20 (4.4%) patients with Gram-negative infections in SDD group and reduced Gram-negative infections by 83% (OR 0.17, 95% CI 0.10 to 0.28, P <0.001) ( Figure  3 ). Heterogeneity was not found ( 2 5.63, P=0.58; I 2 0%).
Fourteen RCTs, including 759 SDD patients and 750 controls, were available for the analysis of Gram-negative lower airway infections 21, 22, 27, 36, 45, 49, 52, 53, 55, 58, 64, 67, 68, 73 . Twenty-four (3.2%) and 170 (22.7%) patients of the SDD and control FIGURE 2: Meta-analysis of aggregate data on oropharyngeal carriage due to Gram-negative microorganism. The 20 trials by first author are: Abele-Horn 21 , Bion 26 Table 2 shows the impact of SDD on Gram-positive carriage and infection. SDD reduced, albeit not overall infections due to Gram-positive bacteria, reduced (OR 0.52, 95% CI 0.34 to 0.78, P=0.0016). Gram-positive bloodstream infections were 95% CI 0.75 to 1.41, P=0.85). Heterogeneity was not found in all comparisons.
Carriage and infection due to Gram-positive bacteria
Subgroup analysis
A subgroup analysis was performed in studies including data on patients with Gram-negative oropharyngeal and rectal carriage, and Gramnegative infections, both overall, lower respiratory tract infections (LRTI) and bloodstream infections (BSI) ( Table 3 ). In general, the association of parenteral and enteral antimicrobials was superior to only enteral antimicrobials in reducing oropharyngeal carriage, rectal carriage, overall infections, LRTI and BSI due to Gram-negative bacteria. The reduction in LRTI and BSI was superior in SDD RCTs in which a proper decontamination was obtained.
The subgroup analysis of the primary endpoints the previous pooled data (Table 4 ). Carriage and overall Gram-positive infections were reduced in the Similarly, bloodstream infections were reduced, randomisation, unblinded and with low quality, and in studies using parenteral and enteral anti-microbials. Lower airway infections due to Gram-positive bacteria were reduced in all subgroups. 
Effect of publication bias
The inspection of the funnel plots for the outcome variables provided no evidence of publication bias (data not shown).
DISCUSSION
This systematic review of 54 randomised controlled trials assessing selective digestive decontamination in approximately 10,000 patients requiring intensive care is the most comprehensive to analyse the microbiology of the SDD-RCTs, both emerge from this meta-analysis:
SDD significantly reduces both carriage and infections due to Gram-negative bacteria;
The impact of SDD on Gram-negative carriage and infection using parenteral and enteral antimicrobials is greater than using only enteral antimicrobials;
The reduction in carriage and infection due to Gram-positive micro-organisms is not significant; lower airway infections due to Grampositive micro-organisms are significantly reduced, while bloodstream infections due to Gram-positive micro-organisms are not significantly increased;
The reduction in serious infections is slightly superior in RCTs in which the patients are successfully decontaminated compared with the RCTs in which successful decontamination is not achieved.
This meta-analysis demonstrates that the enteral antimicrobials of SDD, polymyxin and tobramycin, protect against acquisition and secondary carriage due to Gram-negative micro-organisms transmitted via hands of carers. By design of the technique those two antimicrobials were carefully chosen, as they are synergistic against aerobic Gram-negative bacilli, in particular Pseudomonas aeruginosa 76 , both respect 77, 78 , neutralise endotoxin released by aerobic Gram-negative bacilli 79 and have a low potential for resistance 80 .
Remarkably, the addition of the parenteral antibiotic, mainly cefotaxime, resulted in a more effective clearing of Gram-negative carriage, both oropharyngeal and rectal and reduction in overall Gram-negative infections, LRTI and bloodstream infections compared with RCTs using only enteral antimicrobials. Intravenous cefotaxime is excreted via saliva, bile and mucus into throat and gut, and has been shown to eradicate carriage of 'normal' potential pathogens such as S. pneumoniae, and E. coli 81 . The greater decontamination effect of SDD using parenteral and enteral antimicrobials may be due to the decontamination of E. coli following cefotaxime excretion in throat and gut.
Data from 56 RCTs and 12 meta-analyses do not provide any evidence for a link between SDD and the emergence of antimicrobial resistance 82 . Antimicrobial resistance being a long-term issue, has been evaluated in 11 studies monitoring it • • • • between two and nine years, and bacterial resistance associated with SDD has not been a clinical problem 75, [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] . The experts emphasised that the use of SDD was associated with a Gram-positive problem: however, their claim was mainly based on case reports 93 were the primary endpoints of SDD RCTs in two American ICUs with endemic VRE 23, 44 : there was groups. There are seven RCTs conducted in ICUs where MRSA was endemic at the time of the trial, they report a trend towards higher MRSA carriage and infection rates in patients receiving SDD 34, 36, 39, 43, 50, 70, 71 . Therefore, the results of this systematic review on Gram-positive micro-organisms should be prudently interpreted, as the impact of SDD could depend on the prevalence or endemicity of Gram-positive organisms in a different study population, irrespective of the effect on Gramnegative micro-organisms.
reduced infection rate in RCTs whether the patients were successfully decontaminated or not, i.e. were rendered free of aerobic Gram-negative bacilli or not. This reduction can only be explained by the parenteral component, cefotaxime, that virtually eliminated primary endogenous infections due to admission to the ICU. However, the reduction in infection rate was superior in RCTs in which patients were effectively decontaminated, as there were no secondary endogenous infections in patients rendered free of aerobic Gram-negative bacilli. Similarly, in surgical ICU patients, SDD length of hospital stay only when successful decontamination was achieved [96] [97] [98] .
We acknowledge some limitations of this review. First, the underreporting of the outcome measures may be explained by the fact that the majority of RCTs of SDD were designed to assess the impact of SDD on lower respiratory tract infections and mortality, not the patient's carrier state and the microbiology of carriage and infections. Second, the design of this review excluded urinary tract infections. Only infections of the lower airways and the bloodstream were included as they contribute to mortality 12, 14 . Third, the distinction between Gramnegative and Gram-positive micro-organisms was not always obtainable and episodes of infection rather than patients were frequently used in RCTs, making the calculation of the odds ratio impossible. For example, in two RCTs the number of infectious episodes in the control arm exceeded the number of patients enrolled 46, 57 . Fourth, this review did not include data on the impact of SDD on fungal carriage and infection. Indeed, a previous metareduced both carriage and overall fungal infections, albeit the reduction in fungaemia rate was not 13 . Fifth, by design this review did not distinguish between the type of Gram-negative and Gram-positive microorganism causing infections. This should be taken into account when translating the results of this analysis into clinical practice as mortality is different in severe infections due to the Gram-positive MSSA and MRSA compared with low level pathogens, such as VRE and coagulase-negative staphylococci, and due to the Gram-negative compared with P. aeruginosa. SDD using parenteral and enteral antimicrobials is a prophylactic protocol that targets mainly Gramnegative micro-organisms. Moreover, the reduction of the level of Gram-negative carriage leads to the opponents' assertion 99 that there is strong contravening evidence that SDD promotes infection due to Gram-positive bacteria is unsupported by this review.
